Wiki

Hormone Optimization: Labs, Therapies & Restoration (2026 Guide)

An evidence-based primer on hormone optimization - what's worth measuring, what's worth treating, and how to think about restoration vs. supraphysiologic dosing.

Updated Jan 15, 2026 ·Regen Therapy Editorial Team

Quick answer

Hormone optimization is the clinician-directed process of measuring and restoring the body's endocrine signals—testosterone, estradiol, progesterone, DHEA, thyroid, and cortisol—through labs, lifestyle inputs, and prescribed therapy when appropriate. Treatments range from FDA-approved bioidentical preparations to compounded variants dispensed by Wells Pharmacy Network, always under continuous clinical monitoring with quarterly follow-up labs.

Information presented for educational purposes only.

How do Hormones work?

Total and free testosterone, SHBG, estradiol, DHEA-S, cortisol rhythm, and a full thyroid panel form a baseline. Without that picture, hormone therapy is guesswork.

How do clinicians use Hormones?

Restoration over replacement

Where possible we use peptides like Kisspeptin-10 and Tesamorelin to coax the body's own axes back into rhythm before considering exogenous hormone replacement.

Men's vs. women's pathways

Men's protocols typically center on the HPG axis and testosterone:estradiol balance. Women's protocols are far more cyclical and life-stage dependent - perimenopause, postpartum, and menopause each call for distinct approaches.

Risks and monitoring

Hormone therapy is powerful and worth doing carefully. Expect quarterly labs, blood-pressure tracking, and an annual full review with your clinician.

What are Hormones studied for?

Hormone optimisation is studied for symptom relief, longevity-relevant biomarkers, and quality-of-life endpoints across several distinct populations.

Male hypogonadism and andropause

Testosterone replacement and HPG-axis-restorative agents (clomiphene, enclomiphene, gonadorelin) are studied for their effects on serum testosterone, body composition, mood, and sexual function in men with documented hypogonadism.

Perimenopause and menopause care

Estradiol, progesterone, and DHEA are studied for vasomotor symptoms, sleep, bone density, and genitourinary syndrome of menopause, with ongoing research into long-term cardiovascular and cognitive outcomes.

Thyroid and adrenal axis

TSH, free T3/T4, reverse T3, and morning cortisol are studied as part of comprehensive endocrine workups; treatment ranges from lifestyle inputs to thyroid hormone replacement, depending on the underlying physiology.

Aromatase and oestrogen control

Anastrozole and similar aromatase inhibitors are studied as adjuncts in men on testosterone therapy with elevated estradiol and in oncology contexts. Use is always paired with longitudinal labs.

Which ingredients power Hormones protocols?

Wiki entries on individual ingredients used inside Hormones protocols.

Anastrozole

A non-steroidal aromatase inhibitor that blocks the conversion of androgens to estrogens, FDA-approved for hormone-receptor-positive breast cancer in postmenopausal women.

Clomiphene

A selective estrogen receptor modulator (SERM) FDA-approved for ovulation induction in women, used off-label for HPG-axis support in men.

Cortisol

The principal endogenous glucocorticoid, secreted by the adrenal cortex in a circadian pattern and central to the body's stress, metabolic, and inflammatory signaling.

Desiccated Thyroid

A natural-source thyroid preparation derived from porcine thyroid glands containing both T4 and T3, used in selected hypothyroid patients as an alternative to synthetic levothyroxine.

DHEA

An adrenal steroid hormone that serves as a precursor for downstream androgens and estrogens; available OTC as a dietary supplement and as compounded prescription preparations.

DIM

A metabolite of indole-3-carbinol formed during digestion of cruciferous vegetables, studied for its modulation of estrogen metabolism toward less proliferative pathways.

Enclomiphene

The trans-isomer of clomiphene, a SERM used off-label in male HPG-axis support - favored over racemic clomiphene because it lacks the long-half-life zuclomiphene component.

Estradiol

The primary endogenous estrogen in pre-menopausal women; available in many FDA-approved finished forms and as compounded preparations including pellets.

Estriol

A weaker endogenous estrogen produced primarily during pregnancy; used in compounded bio-identical hormone preparations, especially vaginal applications.

Finasteride

A 5α-reductase type II inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT), FDA-approved for male pattern hair loss and benign prostatic hyperplasia.

Flibanserin

A serotonin 5-HT1A agonist and 5-HT2A antagonist FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women.

Ghrelin

A 28-amino-acid peptide hormone produced primarily by the stomach that signals hunger to the hypothalamus and stimulates pituitary growth-hormone release.

Gonadorelin

A short-chain analog of gonadotropin-releasing hormone that signals the pituitary to release LH and FSH.

Growth Hormone (GH)

A 191-amino-acid pituitary peptide hormone that drives linear growth in childhood and continues to support body composition, recovery, and metabolism in adulthood; recombinant forms (somatropin) are FDA-approved for specific deficiency states.

IGF-1 LR3

A modified analog of insulin-like growth factor-1 with a longer half-life and reduced binding to IGF-binding proteins, studied historically in cell-culture research and in research-informed body-composition protocols.

Insulin

The principal anabolic hormone, secreted by pancreatic beta cells in response to nutrient intake, that drives glucose uptake, glycogen and lipid storage, and protein synthesis.

Kisspeptin-10

A 10-amino-acid C-terminal fragment of kisspeptin that signals the hypothalamus to drive GnRH - and downstream LH and FSH - release.

Leptin

An adipocyte-derived peptide hormone that signals long-term energy stores to the hypothalamus, modulating appetite, energy expenditure, and reproductive and immune function.

Letrozole

A non-steroidal aromatase inhibitor that blocks androgen-to-estrogen conversion; FDA-approved for hormone-receptor-positive breast cancer in postmenopausal women.

Melatonin

A pineal-gland hormone that signals the circadian sleep phase; available OTC as a supplement and as compounded prescription preparations at higher or sustained-release strengths.

Minoxidil

Originally developed as an oral antihypertensive, minoxidil is FDA-approved as a topical for androgenetic alopecia and used off-label as a low-dose oral hair-loss therapy.

Nandrolone

A 19-nortestosterone anabolic-androgenic steroid FDA-approved for anemia of chronic kidney disease and used off-label in selected hormone protocols.

Oxytocin

A nine-amino-acid peptide hormone produced by the hypothalamus, studied for social-bonding signaling, stress modulation, and (commercially) for labor induction.

Progesterone

An endogenous steroid hormone produced primarily by the corpus luteum and placenta; FDA-approved (Prometrium) and compounded preparations are used in hormone-replacement protocols.

PT-141

A melanocortin-receptor agonist studied for central effects on sexual desire - distinct from PDE5 inhibitors that act on blood flow.

Sildenafil

A phosphodiesterase type 5 (PDE5) inhibitor FDA-approved for erectile dysfunction (Viagra) and pulmonary arterial hypertension (Revatio).

T3/T4 (Combination Thyroid)

Compounded combination thyroid preparations containing both liothyronine (T3) and levothyroxine (T4) at clinician-specified ratios, used as an alternative to T4-only therapy.

Tadalafil

A long-acting PDE5 inhibitor FDA-approved for erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension.

Tamoxifen

A selective estrogen receptor modulator FDA-approved for hormone-receptor-positive breast cancer treatment and prevention; used off-label in male HPG-axis protocols.

Testosterone

The principal endogenous androgen in men and a key hormone in women; FDA-approved for hypogonadism and dispensed in many forms including compounded subcutaneous pellets.

Vardenafil

A short-acting PDE5 inhibitor FDA-approved for erectile dysfunction, with a clinical profile broadly similar to sildenafil.

Frequently asked questions about Hormones

Do I need labs before starting hormone therapy?

Yes. A reputable hormone program begins with a baseline lab panel and a clinician evaluation. Without baseline data there is no way to titrate, no way to monitor safety, and no way to know whether the protocol is working.

Is testosterone therapy safe long-term?

When prescribed for a documented indication, dosed carefully, and monitored with regular labs (haematocrit, PSA, lipids, estradiol), the available evidence supports a favourable risk profile in appropriately selected men. It is not appropriate for men without an indication or without ongoing monitoring.

What's the difference between bioidentical and synthetic hormones?

“Bioidentical” means the molecule is identical in structure to what the body produces (e.g. micronised progesterone, estradiol). Synthetic progestins and conjugated equine oestrogens have different structures and different downstream effects. The clinical literature on each is distinct.

How is HRT different in perimenopause vs. menopause?

Perimenopause is a transition with fluctuating ovarian output, so protocols often emphasise cycle support, sleep, and symptom management. Postmenopausal protocols are more about steady-state replacement and long-term bone, cardiovascular, and genitourinary health. Approaches are individualised by clinician.

What labs are typically monitored on therapy?

On testosterone therapy: total and free testosterone, SHBG, estradiol, CBC (haematocrit), PSA, and a lipid panel. On female HRT: estradiol, progesterone, DHEA-S, FSH, and lipid/metabolic panels. Frequency is typically quarterly during titration and at least annually after stabilisation.

Can hormone therapy be combined with peptides?

It often is, intentionally. For example, gonadorelin is sometimes paired with TRT to maintain testicular function, and tesamorelin or CJC-1295 can sit alongside hormone protocols for body-composition and recovery goals. Combinations are designed by the prescribing clinician.

Where can I read the source research?

Research and clinical use

Compounds discussed on this page are intended for laboratory and clinical research only. They are not approved by the FDA for human use outside of an authorized clinical context. This page is informational and is not medical advice. Always speak with a qualified clinician before starting, stopping, or changing any therapy.

Ready to look at protocols?

Browse the catalog or start a clinician evaluation. Every prescription is reviewed by a licensed clinician.

Browse hormone protocols →